Showing results (41-50 of 404) with videos related to

Sort By:
Pageof 41
International Journal of Urology : Official Journal of the Japanese Urological Association|May 9, 2008
The efficacy of laparoscopic radical nephrectomy for renal cell cancer in the elderly: an oncological outcome analysisMasahiko Harano, Masatoshi Eto, Akira Yokomizo, et al.
European Journal of Pharmacology|October 21, 2017
Role of K+ channels in regulating spontaneous activity in the muscularis mucosae of guinea pig bladderKen Lee, Ayu Isogai, Minori Antoh, et al.
Endocrine-Related Cancer|July 28, 2022
Androgen receptor mutations for precision medicine in prostate cancerMasaki Shiota, Shusuke Akamatsu, Shigehiro Tsukahara, et al.
Urology Practice|April 27, 2023
Adverse Events of Abiraterone Acetate vs EnzalutamideLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.
Cancer Science|August 9, 2017
Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor modelsYuichi Iida, Nanae Harashima, Takanobu Motoshima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 3, 2008
Laparoscopic adrenalectomy for malignant tumorsMasatoshi Eto, Masumitsu Hamaguchi, Masahiko Harano, et al.
Scientific Reports|February 6, 2019
Reconstitution of the embryonic kidney identifies a donor cell contribution to the renal vasculature upon transplantationYoichi Murakami, Hidekazu Naganuma, Shunsuke Tanigawa, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|January 12, 2008
Comparison of standard and hand-assisted laparoscopic radical nephrectomy for renal cell carcinomaMasahiko Harano, Masatoshi Eto, Akira Yokomizo, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 11, 2020
Family history in primary hormone therapy for prostate cancer: Analysis from a community-based multi-institutional Japan-wide databaseMasaki Shiota, Mizuki Onozawa, Shiro Hinotsu, et al.
Clinical Genitourinary Cancer|October 9, 2023
Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus NivolumabLeandro Blas, Masaki Shiota, Shigehiro Tsukahara, et al.
Pageof 41